2019
DOI: 10.1002/jcp.29335
|View full text |Cite
|
Sign up to set email alerts
|

Progenitor‐cell‐enriched micrografts as a novel option for the management of androgenetic alopecia

Abstract: Regenerative medicine is a multidisciplinary field that combines engineering and life science principles to promote regeneration, potentially restoring the physiological condition in diseased tissues. Specifically, the developments of complex grafts enhance the intrinsic regenerative capacity of the host by altering its environment.Autologous micrografts obtained through Rigenera ® micrografting technology are able to promote derma and bone regeneration. Androgenetic alopecia (AGA) leads to

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 31 publications
0
14
0
Order By: Relevance
“…In vitro studies have shown that mechanically obtained micrografts are enriched with mesenchymal progenitor cells, growth factors, and extracellular matrix components [19,23]. The technology has been successfully applied in different clinical contexts: dentistry field [13], dermatology for androgenetic alopecia [9,24], traumatology for chondropathy [14], osteonecrosis [15], and cardiology field for cardiac ischemia [16]. Our present result demonstrated that micrografts helped a severe intractable wound to generate qualified granulation tissue.…”
Section: Discussionmentioning
confidence: 56%
“…In vitro studies have shown that mechanically obtained micrografts are enriched with mesenchymal progenitor cells, growth factors, and extracellular matrix components [19,23]. The technology has been successfully applied in different clinical contexts: dentistry field [13], dermatology for androgenetic alopecia [9,24], traumatology for chondropathy [14], osteonecrosis [15], and cardiology field for cardiac ischemia [16]. Our present result demonstrated that micrografts helped a severe intractable wound to generate qualified granulation tissue.…”
Section: Discussionmentioning
confidence: 56%
“…20 More recently, Ruiz et al studied the efficacy of ACM at 4, 6 and 12 months, among 100 AGA and showed significant increase in hair density (+33.3/cm 2 ) and percentage of thick hair (+5.6%) at 2 months. 21 …”
Section: Discussionmentioning
confidence: 99%
“…To date, the Rigenera® micrografting technology has demonstrated its efficacy in different clinical setting. It is widely used with dermal tissue sample for the treatment of complex wounds, such as dehiscences, chronic ulcers, and burns [ 17 , 18 , 19 , 20 , 21 , 22 ]; for dermatological applications, such as hypertrophic scars [ 23 ]; and for the management of androgenetic alopecia [ 24 , 25 ]; with cartilage samples for the management of chondropathy [ 26 , 27 ]; and with bone samples for the treatment of the osteonecrosis of the femoral head [ 28 ].…”
Section: Discussionmentioning
confidence: 99%